We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
+7.69%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$42.3B
AUM Growth
+$5.51B
(+15%)
Cap. Flow
+$3.13B
Cap. Flow
% of AUM
7.41%
Top 10 Holdings %
Top 10 Hldgs %
26.06%
Holding
1,338
New
111
Increased
793
Reduced
350
Closed
65
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$238M |
| 2 |
CGAU
Centerra Gold
CGAU
|
+$212M |
| 3 |
Halliburton
HAL
|
+$181M |
| 4 |
Baker Hughes
BKR
|
+$115M |
| 5 |
ServiceNow
NOW
|
+$103M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gold Fields
GFI
|
+$374M |
| 2 |
John Wiley & Sons Class A
WLY
|
+$96.5M |
| 3 |
Bank of America
BAC
|
+$90.9M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$89.1M |
| 5 |
US Bancorp
USB
|
+$84.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 40.42% |
| 2 | Technology | 21.38% |
| 3 | Energy | 8.67% |
| 4 | Healthcare | 6.57% |
| 5 | Financials | 3.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
JD.com
JD
$44.6B
| $13.9M | 0.03% |
174,534
+62,214
| +55% | +$4.68M |
|
302
Automatic Data Processing
ADP
$106B
| $13.9M | 0.03% |
69,788
+12,564
| +22% | +$2.44M |
|
303
CVS Health
CVS
$133B
| $13.8M | 0.03% |
165,079
-12,236
| -7% | -$1M |
|
304
TJX Companies
TJX
$174B
| $13.7M | 0.03% |
203,902
+44,893
| +28% | +$3.06M |
|
305
Cencora
COR
$60.6B
| $13.6M | 0.03% |
118,883
+3,544
| +3% | +$419K |
|
306
Dollar General
DG
$28B
| $13.6M | 0.03% |
62,699
+13,467
| +27% | +$2.83M |
|
|
MFA
307
MFA Financial
MFA
$926M
| $13.5M | 0.03% |
733,713
+102,571
| +16% | +$1.81M |
|
|
GPL
308
DELISTED
Great Panther Mining Limited
GPL
| $13.4M | 0.03% |
2,147,989
+96,048
| +5% | +$732K |
|
309
MidCap Financial Investment
MFIC
$787M
| $13.3M | 0.03% |
970,737
-150,992
| -13% | -$2.16M |
|
310
POSCO
PKX
$16.1B
| $13.2M | 0.03% |
172,344
+51,966
| +43% | +$4.11M |
|
311
Simon Property Group
SPG
$74.4B
| $13.1M | 0.03% |
100,749
+44,086
| +78% | +$5.48M |
|
312
AstraZeneca
AZN
$263B
| $13.1M | 0.03% |
109,231
-13,468
| -11% | -$1.48M |
|
|
ADAM
313
Adamas Trust
ADAM
$815M
| $13M | 0.03% |
726,159
+108,077
| +17% | +$1.97M |
|
|
GLDG
314
GoldMining Inc
GLDG
$178M
| $13M | 0.03% |
9,006,199
+402,713
| +5% | +$655K |
|
315
BlackRock TCP Capital
TCPC
$273M
| $12.8M | 0.03% |
923,970
-155,319
| -14% | -$2.24M |
|
316
AT&T
T
$159B
| $12.6M | 0.03% |
580,562
+103,366
| +22% | +$2.35M |
|
317
VanEck IG Floating Rate ETF
FLTR
$2.94B
| $12.6M | 0.03% |
495,100
+100,000
| +25% | +$2.54M |
|
318
Teva Pharmaceuticals
TEVA
$40.8B
| $12.1M | 0.03% |
1,217,142
+404,483
| +50% | +$4.28M |
|
319
NewtekOne
NEWT
$428M
| $11.9M | 0.03% |
342,035
-44,571
| -12% | -$1.4M |
|
|
NVO
320
Novo Nordisk
NVO
$208B
| $11.9M | 0.03% |
283,040
-40,002
| -12% | -$1.55M |
|
321
Bain Capital Specialty
BCSF
$806M
| $11.8M | 0.03% |
774,495
-9,568
| -1% | -$151K |
|
322
Sanofi
SNY
$103B
| $11.8M | 0.03% |
223,864
-17,761
| -7% | -$927K |
|
323
Welltower
WELL
$169B
| $11.7M | 0.03% |
141,268
+63,119
| +81% | +$4.83M |
|
324
Novartis
NVS
$297B
| $11.7M | 0.03% |
128,110
-9,498
| -7% | -$846K |
|
325
Carlyle Secured Lending
CGBD
$694M
| $11.5M | 0.03% |
874,092
-154,412
| -15% | -$2.1M |
|
Similar funds
VanEck Associates's Q2 2021 Portfolio in Review
As of Q2 2021, VanEck Associates held 1,338 positions worth $42.3B, up 15% from $36.8B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
VanEck Associates deployed $3.13B of net new capital in Q2 2021, opening 111 new positions and adding to 793 existing holdings. Its largest new stake was Centerra Gold: 25,491,475 shares worth $193M.
By sector, the portfolio is most concentrated in Materials at 40% of assets, down from 43% a quarter earlier, followed by Technology and Energy.
On the sell side, the largest reduction was Gold Fields, an estimated $374M trimmed.
- VanEck Associates's largest Q2 2021 buy was Centerra Gold: 25,491,475 shares worth $193M.
- VanEck Associates added most to SLB Ltd in Q2 2021, an estimated $238M increase.
- VanEck Associates's biggest Q2 2021 reduction was Gold Fields, cutting an estimated $374M.
- VanEck Associates fully exited John Wiley & Sons Class A in Q2 2021, selling an estimated $96.5M.
- VanEck Associates's ten largest holdings make up 26% of its $42.3B portfolio in Q2 2021.
- VanEck Associates opened 111 new positions and closed 65 in Q2 2021.
- VanEck Associates's portfolio value rose 15% quarter-over-quarter to $42.3B.
Based on VanEck Associates's 13F filing for Q2 2021, filed 10 Aug 2021.